26 April 2017 - Deborah Wilkes
Archived
Sales at RB's Health division were flat on a like-for-like basis in the first quarter of 2017. The company said "strong, broad-based growth" across the portfolio had been offset by declines for Scholl/Amopé footcare products.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.